Member Exclusive News

The week in industry: Nasal spray to treat depression gets FDA committee approval

This week: Moderna reports positive interim results from its Phase I vaccine study, Grey Wolf completes series A financing to secure US $14 million to develop immuno-oncology therapeutics and Charles River Laboratories continue to expand their early-stage CRO activity.

Go to the profile of RxNet
Feb 14, 2019
0
0

Please sign in or register for FREE

No comments yet.